Txioak
- Txioak, current page.
- Txioak eta erantzunak
- Media
You blocked @AdaptiveBiotech
Are you sure you want to view these Tweets? Viewing Tweets won't unblock @AdaptiveBiotech
-
Adaptive Biotech(e)k Bertxiotua
.
@NCITreatment and@AdaptiveBiotech are working together to advance the science behind#immunotherapy of#cancer! https://goo.gl/WyRETjMilesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Flattered to be described as a WA State rising star by
@CNBC & congrats to WA State! Named best place for business.http://www.cnbc.com/2017/07/11/washington-is-americas-top-state-for-business-in-2017.html …Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Congrats to "Hootie" Warren
@fredhutch "using science to help people around the world" as head of Global Oncologyhttp://ow.ly/sKvv30dU9FUMilesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Adaptive Biotech(e)k Bertxiotua
.
@AdaptiveBiotech's Dr Sharon Benzeno discusses "Predictive Potential of TCRB Sequencing in IO Treated Patients."#IOCombos360pic.twitter.com/9YmYkNpoVI
Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
“We don’t have the best [treatments] yet. We have to do better”. Dr. Stanley Riddell
#drivinginnovation#CIM17 http://bit.ly/1OiqjXD pic.twitter.com/UPDYizp2ZG
Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Learn more about our role in supporting
#immunotherapy development & treatment using#immunosequencing here: http://bit.ly/2triWL4#CIM17Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Partnering w/
#DARZALEX to demonstrate utility of#clonoSEQ for tracking MRD negativity in#myeloma patients.#EHA17 http://www.adaptivebiotech.com/news/adaptive-biotechnologies-announces-collaboration-janssen-biotech-inc-use-clonoseq%C2%AE-assay …Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin
-
#clonoSEQ#NGS-based#MRD will be used for late-stage#DARZALEX#myeloma trials.@JNJInnovation Learn about MRD: http://www.adaptivebiotech.com/clonoseq/the-importance-of-mrd/#why-measure-mrd …Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin
-
New Adaptive pharma collaboration shows the value of
#MRD quantification & tracking by#clonoSEQ in drug dev.#EHA17 http://www.adaptivebiotech.com/news/adaptive-biotechnologies-announces-collaboration-janssen-biotech-inc-use-clonoseq%C2%AE-assay …Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Proud to partner w
@JanssenGlobal to help measure depth of response of MM pts in DARZALEX trial w clonoSEQ Assay. http://bit.ly/2tSzjARMilesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin
-
Adaptive announces collaboration w/
@JanssenGlobal using#clonoSEQ to enhance#DARZALEX drug dev in#myeloma.#EHA17 http://www.adaptivebiotech.com/news/adaptive-biotechnologies-announces-collaboration-janssen-biotech-inc-use-clonoseq%C2%AE-assay …Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Adaptive Biotech(e)k Bertxiotua
Congrats to Dr. Harlan Robins (of
#FredHutch &@AdaptiveBiotech) on his Pacific NW Entrepreneur of the Year Award. http://www.fredhutch.org/en/news/center-news/2017/06/eduardo-mendez-gets-nih-grant-head-neck-cancers.html#robins …pic.twitter.com/p42oVpeomu
Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Learn more about our role in supporting
#immunotherapy development & treatment using#immunosequencing here: http://bit.ly/2triWL4#CIM17Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Know thy self, know thy enemy—Sun Tzu. The Cancer Immunity Cycle in seven steps.
#CIM17#immunotherapypic.twitter.com/zzwc9M4fQ5
Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Learn more about our role in supporting
#immunotherapy development & treatment using#immunosequencing here: http://bit.ly/2triWL4#CIM17Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
The goal of
#immunotherapy: give your immune system the upper hand in fighting cancer and restore its power.#CIM17pic.twitter.com/JBaOqMG7n9
Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin -
Chad Robins
@AdaptiveBiotech & Brad Gray@nanostringtech discuss immune system monitoring in immunotherapy research w Alex Lash#xconSEApic.twitter.com/7DZkH2bWhd
Milesker. Twitterrek zure denbora lerroa hobetzeko erabiliko du hau. Desegin
Badirudi kargak luze hartuko duela.
Baliteke Twitterren kapazitatez gaindi egotea edo momentuko gainkarga bat izatea. Berriro saiatu edo Twitterren Egoera ikusi informazio gehiagorako.